Showing results (231-240 of 403) with videos related to

Sort By:
Pageof 41
Cell Reports|July 30, 2023
Sex shapes cell-type-specific transcriptional signatures of stress exposure in the mouse hypothalamusElena Brivio, Aron Kos, Alessandro Francesco Ulivi, et al.
Scientific Reports|May 4, 2017
Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumabGiorgia Marisi, Emanuela Scarpi, Alessandro Passardi, et al.
Frontiers in Immunology|May 2, 2022
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory AnalysisGiuseppe Bronte, Elisabetta Petracci, Serena De Matteis, et al.
ESMO Open|October 22, 2023
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trialN Brighi, V Conteduca, G Gurioli, et al.
Neoplasia (New York, N.Y.)|April 2, 2005
Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma modelsPaola Ulivi, Wainer Zoli, Francesco Fabbri, et al.
British Journal of Cancer|November 8, 2007
Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational studyR Gunelli, E Bercovich, O Nanni, et al.
Diagnostics (Basel, Switzerland)|May 6, 2020
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of PatientsGianluca Tedaldi, Michela Tebaldi, Valentina Zampiga, et al.
European Journal of Human Genetics : EJHG|January 21, 2011
Association of a variant in the CHRNA5-A3-B4 gene cluster region to heavy smoking in the Italian populationRossella Sorice, Silvia Bione, Serena Sansanelli, et al.
Clinical and Experimental Immunology|March 24, 2025
Type I interferon signature: a quantitative standardized method for clinical applicationAlessandra Tesser, Paola Bocca, Massimo Ulivi, et al.
BMC Cancer|July 9, 2016
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case reportAndrea Casadei Gardini, Elisa Chiadini, Luca Faloppi, et al.
Pageof 41